| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $538.9M | +42.0% |
| Cost of Revenue | $39.8M | +39.6% |
| R&D Expense | $77.6M | +24.8% |
| SG&A Expense | $58.2M | +51.2% |
| Operating Income | -$19.0M | +51.3% |
| Interest Expense | $2.5M | +92.3% |
| Pre-tax Income | -$20.0M | +46.9% |
| Income Tax | -$9.8M | -304.2% |
| Net Income | -$10.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.9M | -50.0% |
| Accounts Receivable | $87.0M | +51.0% |
| Current Assets | $189.2M | -22.1% |
| Total Assets | $425.7M | +16.9% |
| Current Liabilities | $72.4M | +10.0% |
| Total Liabilities | $84.0M | -21.1% |
| Stockholders' Equity | $341.7M | +32.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.0M | +247.2% |
| Capital Expenditures | $4.6M | +100.0% |
| Investing Cash Flow | -$100.3M | -336.1% |
| Financing Cash Flow | -$8.4M | -108.4% |
| Free Cash Flow | $20.4M | +316.3% |
| +76.0% |
| EPS (Basic) | -$0.14 | +82.9% |
| EPS (Diluted) | -$0.14 | +82.9% |